Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
At the award ceremony, the nation's top infectious disease expert spoke about his decades-long effort to end the HIV/AIDS crisis (see video in the article).
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.
Obstacles remain before the world reaches the point of eliminating AIDS, but new prevention technologies and outreach programs are reasons to be optimistic about the future.
The diminished power of the immune system in older adults is usually blamed on the aging process. A new study shows that decades of inhaled particulates due to air pollution also take a toll.
Initial reports of the bivalent booster’s effectiveness have created confusion among the public. David Ho discusses his own results, the bottom line, and what to expect from COVID this winter.
Cases of COVID, influenza, and RSV are surging in children and adults, along with a slew of other infectious diseases that went under the radar during the first two years of the pandemic.